Moreno, Raúl
Souza, José
Smolnik, Rüdiger
Nombela-Franco, Luis
Van Mieghem, Nicolas M.
Hengstenberg, Christian
Valgimigli, Marco
Jin, James
Ohlmann, Patrick
Dangas, George
Unverdorben, Martin
Möllmann, Helge
Funding for this research was provided by:
Daiichi Sankyo, Inc
Article History
Received: 25 July 2023
Accepted: 10 January 2024
First Online: 31 January 2024
Declarations
:
: The ENVISAGE-TAVI AF protocol was approved by the ethics committees and corresponding health authorities for all sites. All patients provided written informed consent before enrollment.
: <b>RM</b> received payments for personal fees from Abbott Vascular, AMGEN, Biosensors, Boston Scientific, Daiichi Sankyo, Edwards Lifesciences, Ferrer, Medtronic, Philips, and Terumo; <b>LNF</b> is a proctor for Abbott Medical and received personal fees from Abbott Medical, Boston Scientific, and Edwards Lifesciences; <b>NVM</b> received grants or contracts from Abbott, Abiomed, Boston Scientific, Daiichi Sankyo, Edwards Lifesciences, Medtronic, PulseCath BV, and Siemens; <b>CH</b> is a clinical proctor for Edwards Lifesciences and Boston Scientific; received research grants to institution from Abbott, Boston Scientific, Edwards Lifesciences, and Medtronic; and reports payment for speaker bureaus and support for attending meetings from Daiichi Sankyo and advisory board participation for Daiichi Sankyo; <b>MV</b> received grants and personal fees from Terumo and has received personal fees from AstraZeneca, Alvimedica/CID, Abbott Vascular, Daiichi Sankyo, Bayer, CoreFlow, Idorsia Pharmaceuticals LTD, Universität Basel, Dept. Klinische Forschung, Vifor, Bristol Myers Squibb SA, Biotronik, Boston Scientific, Medtronic, Vesalio, Novartis, Chiesi, and PhaseBio; <b>PO</b> has nothing to disclose; <b>HM</b> received personal fees from Daiichi Sankyo, Pfizer, Bristol Myers Squibb, Boehringer Ingelheim, Edwards Lifesciences, Boston Scientific, Abbott Medical, and AstraZeneca and support for attending meetings from Daiichi Sankyo, Pfizer, Edwards Lifesciences, Boston Scientific, Abbott Medical, and AstraZeneca; <b>GD</b> received research grants to institution and support for attending meetings from Bayer and Daiichi Sankyo and consulting fees from Daiichi Sankyo; and <b>JS, RS, JJ,</b> and <b>MU</b> are employees of Daiichi Sankyo.